Nektar Therapeutics (NKTR)
0.60
-0.04 (-5.91%)
At close: Apr 16, 2025, 3:59 PM
0.61
0.96%
After-hours: Apr 16, 2025, 08:00 PM EDT
Nektar Therapeutics Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License Collaboration And Other Revenue Revenue | 378K | 97K | 341K | 155K | 9K | 15K | 17K | 314K | 9K | 1.57M | 40K | 314K | 28K | 54K | 428K | 1.63M | 26.27M | 27.52M | 7.12M | 3.12M | 2.54M | 4.2M | 8.97M | 8.37M | 9.04M |
| License Collaboration And Other Revenue Revenue Growth | +289.69% | -71.55% | +120.00% | +1622.22% | -40.00% | -11.76% | -94.59% | +3388.89% | -99.43% | +3832.50% | -87.26% | +1021.43% | -48.15% | -87.38% | -73.76% | -93.79% | -4.51% | +286.72% | +127.97% | +23.12% | -39.70% | -53.14% | +7.15% | -7.44% | n/a |
| Non Cash Royalty Revenue Related To Sale Of Future Royalties Revenue | 15.73M | 15.51M | 18.06M | 18.17M | 15.83M | 16.86M | 17.63M | 18.34M | 16.26M | 17.56M | 19.08M | 19.41M | 20.46M | 18.8M | 20.56M | 10.42M | 7.68M | 9.89M | 8.72M | 10.26M | 9.09M | 8.23M | n/a | n/a | n/a |
| Non Cash Royalty Revenue Related To Sale Of Future Royalties Revenue Growth | +1.44% | -14.14% | -0.58% | +14.75% | -6.10% | -4.35% | -3.90% | +12.78% | -7.39% | -7.96% | -1.72% | -5.10% | +8.82% | -8.58% | +97.29% | +35.63% | -22.34% | +13.50% | -15.06% | +12.90% | +10.46% | n/a | n/a | n/a | n/a |
| Product Revenue | 8.02M | 6.03M | 5.48M | 5.82M | 4.66M | 4.72M | 4.38M | 4.97M | 5.31M | 5.69M | 5.89M | 5.19M | 7.85M | 4.79M | 2.88M | 5.69M | 5.49M | 3.44M | 5.82M | 5.56M | 4.35M | 4.4M | n/a | n/a | n/a |
| Product Revenue Growth | +32.83% | +10.05% | -5.82% | +24.99% | -1.27% | +7.74% | -11.87% | -6.46% | -6.61% | -3.43% | +13.40% | -33.80% | +63.63% | +66.26% | -49.32% | +3.76% | +59.26% | -40.77% | +4.62% | +27.89% | -1.18% | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 78.64M | 82.21M | 91.79M | 87.95M | 87.52M | 1.09B | 190.81M | 39.15M | 32.51M |
| Non-Us Revenue Growth | -4.35% | -10.44% | +4.37% | +0.49% | -91.98% | +471.67% | +387.42% | +20.40% | n/a |
| United States Revenue | 11.48M | 9.84M | 10.11M | 64.97M | 27.09M | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +16.66% | -2.70% | -84.43% | +139.79% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 18.96M | 20.51M | 20.15M | 17.32M | 21.15M | 17.87M | 21.08M | 21.94M | 22.53M | 20.52M | 27.34M | 32.14M | 29.47M | 29.55M | 31.68M | 27.14M | 26.98M | 24.35M | 26.22M | 27.14M | 23.98M | 22.58M | 25.01M | 23.78M | 18.72M | 20.26M | 18.69M | 12.34M | 12.05M | 16M | 11.98M | 12.76M | 10.25M | 11.04M | 10.23M | 13.23M | 9.54M | 10.18M | 10.3M |
| Selling, General, and Administrative Revenue Growth | -7.57% | +1.79% | +16.33% | -18.10% | +18.34% | -15.24% | -3.91% | -2.64% | +9.81% | -24.94% | -14.94% | +9.07% | -0.29% | -6.70% | +16.74% | +0.57% | +10.82% | -7.13% | -3.41% | +13.17% | +6.21% | -9.70% | +5.17% | +27.03% | -7.62% | +8.42% | +51.47% | +2.34% | -24.64% | +33.57% | -6.14% | +24.45% | -7.09% | +7.89% | -22.72% | +38.67% | -6.28% | -1.16% | n/a |
| Research and Development Revenue | 35.03M | 29.72M | 27.41M | 29.94M | 24.07M | 29.68M | 30.47M | 34.74M | 33.59M | 42.74M | 107.25M | 99.61M | 103.74M | 101.31M | 95.6M | 102.72M | 100.53M | 96.44M | 108.99M | 110.37M | 99.05M | 106.69M | 118.46M | 108.88M | 102.89M | 88.33M | 99.42M | 81.43M | 65.71M | 60.26M | 61.06M | 50.23M | 51.95M | 52.35M | 49.27M | 47.13M | 43.23M | 45.41M | 47.01M |
| Research and Development Revenue Growth | +17.85% | +8.45% | -8.46% | +24.40% | -18.90% | -2.59% | -12.29% | +3.42% | -21.41% | -60.15% | +7.67% | -3.98% | +2.39% | +5.97% | -6.93% | +2.18% | +4.25% | -11.52% | -1.25% | +11.43% | -7.16% | -9.94% | +8.80% | +5.82% | +16.48% | -11.15% | +22.10% | +23.91% | +9.05% | -1.31% | +21.55% | -3.31% | -0.76% | +6.26% | +4.53% | +9.04% | -4.81% | -3.40% | n/a |